Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?

Br J Ophthalmol. 2000 May;84(5):531-3. doi: 10.1136/bjo.84.5.531.

Abstract

Aims: To investigate whether lupus anticoagulant (LA) positivity, a marker of endothelial dysfunction, might be relevant to the pathogenesis of diabetic retinopathy (DR).

Methods: 32 IDDM patients were examined for LA, fibrinogen, prothrombin (PT), PTT, prothrombin degradation products (F1+2), and activated protein C (APC).

Results: APC decreased and F1+2 increased significantly in LA positive but not in LA negative patients; 60% of LA positive and 18% of LA negative subjects had DR. PT, PTT, and fibrinogen levels were insignificant.

Conclusion: These preliminary findings suggest that LA positivity could represent an additional risk factor for DR, acting as a link between the immunological and haemostatic systems.

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetic Retinopathy / blood
  • Diabetic Retinopathy / immunology*
  • Female
  • Humans
  • Lupus Coagulation Inhibitor / blood*
  • Male
  • Middle Aged
  • Peptide Fragments / blood
  • Protein C / metabolism
  • Prothrombin / metabolism
  • Risk Factors

Substances

  • Lupus Coagulation Inhibitor
  • Peptide Fragments
  • Protein C
  • Prothrombin